Cytokinetics | CYTK - Stock


Cytokinetics reported $0 in Stock for its fiscal quarter ending in December of 2023.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cytokinetics USD 0 0 Dec/2023
Eisai JPY 227.32B 11.41B Jun/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Exelixis USD 27.4M 3.92M Sep/2025
Geron USD 95.42M 26.3M Sep/2025
Halozyme Therapeutics USD 185.8M 4.29M Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Ligand Pharmaceuticals USD 11.9M 3.59M Sep/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025